2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209)
Chemical | Endpoint Value | Endpoint Description | Sex | Life Cycle Stage | Sample Size | Location | Type | California Counties | Countries | Lab |
---|---|---|---|---|---|---|---|---|---|---|
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 6377 ng/g ww | Fat concentration | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 384 ng/g ww | Liver concentration | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 1583 ng/g ww | Plasma concentration | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 194 ng/g ww | Plasma concentration | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 14 d | Half-life | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | See citation | Plasma/organ PBDE congener concentrations | B | Adult | 34 | Toxicity Factor Datasets | Lab | CANADA | Laboratory | |
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 0.49 µg/g lw | Egg concentration | Embryo | 95 | Toxicity Factor Datasets | USA | ||||
2,2',3,3',4,4',5,5',6,6'-DECABROMODIPHENYL ETHER (BDE-209) | 6.35 ng/g ww | Egg concentration | Embryo | 11 | MD, VA | Toxicity Factor Datasets | USA |